Evidence map›Paper›PMID 30072687›Full record

ArticleNature communications2018

Interleukin-2 induces the in vitro maturation of human pluripotent stem cell-derived intestinal organoids.

Kwang Bo Jung, Hana Lee, Ye Seul Son, Mi-Ok Lee, Young-Dae Kim, Soo Jin Oh, Ohman Kwon, Sunwha Cho, Hyun-Soo Cho, Dae-Soo Kim and 6 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed
5.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 117 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Organoid-based modeling and regenerative strategies for salivary gland dysfunction.The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology · 2025
    Review
  11. Apoptosis-Inducing Effects ofJournal of microbiology and biotechnology · 2025
    Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 2 countries.

Kwang Bo JungKorea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, 34141, Republic of Korea.
Hana LeeKorea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, 34141, Republic of Korea.
Ye Seul SonKorea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, 34141, Republic of Korea.
Mi-Ok LeeKorea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, 34141, Republic of Korea.
Young-Dae KimKorea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, 34141, Republic of Korea.
Soo Jin OhAsan Institute for Life Sciences, Asan Medical Center & Department of Convergence medicine, College of Medicine, University of Ulsan, Seoul, 05505, Republic of Korea.
Ohman KwonKorea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, 34141, Republic of Korea.
Sunwha ChoKorea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, 34141, Republic of Korea.
Hyun-Soo ChoKorea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, 34141, Republic of Korea.
Dae-Soo KimKorea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, 34141, Republic of Korea.
Jung-Hwa OhKorea Institute of Toxicology, Daejeon, 34114, Republic of Korea.
Matthias ZilbauerDepartment of Paediatric Gastroenterology, Hepatology and Nutrition, Cambridge University Hospitals, Addenbrooke's, Cambridge Biomedical Campus, Hills Road, Cambridge, CB2 0QQ, UK.
Jeong-Ki MinKorea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, 34141, Republic of Korea.
Cho-Rok JungKorea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, 34141, Republic of Korea. crjung@kribb.re.kr.
Janghwan KimKorea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, 34141, Republic of Korea. janghwan.kim@kribb.re.kr.ORCID http://orcid.org/0000-0003-3227-958X
Mi-Young SonKorea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, 34141, Republic of Korea. myson@kribb.re.kr.ORCID http://orcid.org/0000-0001-7590-8812
Korea Research Institute of Bioscience and Biotechnology · KRAsan Medical Center · KRCambridge University Hospitals NHS Foundation Trust · GBKorea Institute of Toxicology · KR

Funding

Korea Research Institute of Bioscience and Biotechnology (KRIBB) KRIBB Research Initiative ProgramNational Research Foundation of Korea (NRF) 2016R1A2B4013501
6 · The paper itself

Abstract

Human pluripotent stem cell (hPSC)-derived intestinal organoids (hIOs) form 3D structures organized into crypt and villus domains, making them an excellent in vitro model system for studying human intestinal development and disease. However, hPSC-derived hIOs still require in vivo maturation to fully recapitulate adult intestine, with the mechanism of maturation remaining elusive. Here, we show that the co-culture with human T lymphocytes induce the in vitro maturation of hIOs, and identify STAT3-activating interleukin-2 (IL-2) as the major factor inducing maturation. hIOs exposed to IL-2 closely mimic the adult intestinal epithelium and have comparable expression levels of mature intestinal markers, as well as increased intestine-specific functional activities. Even after in vivo engraftment, in vitro-matured hIOs retain their maturation status. The results of our study demonstrate that STAT3 signaling can induce the maturation of hIOs in vitro, thereby circumventing the need for animal models and in vivo maturation.

Indexed as

BiomarkersCell DifferentiationCoculture TechniquesHumansInterleukin-2IntestinesOrganoidsPluripotent Stem CellsSignal TransductionSTAT3 Transcription FactorT-LymphocytesBiomarkersInterleukin-2STAT3 Transcription Factor

Identifiers

PMID30072687
PMCPMC6072745
OpenAlexW2883753684

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.